Figure 3
From: IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients

Actuarial 2 year local disease free survival according to the T-stages.
From: IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients
Actuarial 2 year local disease free survival according to the T-stages.